A recent study indicates that patients who stop using new GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise regimens.
Published data in a leading medical journal demonstrates that while obese individuals often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing such drugs need to be informed of the potential of fast weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to original weight in about one and a half years.
Analyzing Therapies
The research, which reviewed dozens of trials involving over 9,000 of participants, compared the effects of these new drugs with conventional dieting.
The team point out that individuals who lose weight through diet and exercise usually experience a slower creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Experts suggest the way of the jabs explains the amplified weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.
"Stopping of this medication results in hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals argue that, given the high risk of relapse, the therapy is often ongoing.
This perspective is supported by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," akin to managing diseases like diabetes.
User Testimonies
People who have stopped the medication explain a intense return of appetite.
"It felt as if a trigger flipping and I was suddenly starving," said an individual.
This challenge is exacerbated if users have not developed lasting dietary or behavioural modifications during treatment.
Significant Interest
Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with interest being substantial.
- Adoption is higher among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while these medications are powerful tools for weight loss, they are not a standalone solution and lasting health benefits hinges on combined lifestyle management.
